Compare SEM & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEM | OGN |
|---|---|---|
| Founded | 1996 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2008 | 2020 |
| Metric | SEM | OGN |
|---|---|---|
| Price | $16.27 | $6.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $15.17 | $11.75 |
| AVG Volume (30 Days) | ★ 3.1M | 3.0M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.54% | 1.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.16 | 0.72 |
| Revenue | N/A | ★ $6,216,000,000.00 |
| Revenue This Year | $5.45 | $0.42 |
| Revenue Next Year | $4.78 | $1.67 |
| P/E Ratio | $14.02 | ★ $8.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.65 | $6.03 |
| 52 Week High | $18.61 | $15.36 |
| Indicator | SEM | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 63.73 | 29.92 |
| Support Level | $16.20 | N/A |
| Resistance Level | $16.30 | $7.87 |
| Average True Range (ATR) | 0.04 | 0.21 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 70.00 | 26.54 |
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.